Case, Siobhan M. http://orcid.org/0000-0003-0300-0586
Nigrovic, Peter A. http://orcid.org/0000-0002-2126-3702
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (2P30AR070253, 2R01AR065538, R01AR075906, R01AR073201)
Article History
Accepted: 21 February 2022
First Online: 1 April 2022
Declarations
:
: PAN is funded by NIAMS awards 2R01AR065538, R01AR075906, R01AR073201, 2P30AR070253; the FundaciĆ³n Bechara; and the Arbuckle Family Fund for Arthritis Research.
: PAN receives investigator-initiated research grants from Bristol-Myers Squibb and Pfizer; consulting from Bristol-Myers Squibb (BMS), Cerecor, Exo Therapeutics, Miach Orthopedics, Novartis, and Pfizer; royalties from UpToDate Inc.; and salary support from the Childhood Arthritis and Rheumatology Research Alliance.
: Not applicable.
: Not applicable.
: Not applicable.
: all materials were publicly available.
: Not applicable.
: PAN and SC made substantial contributions to the conception/design of the work; drafted the work or revised it critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Both authors read and approved the final version.